These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17804227)

  • 21. Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitors.
    Wang L; Sullivan GM; Hexamer LA; Hasvold LA; Thalji R; Przytulinska M; Tao ZF; Li G; Chen Z; Xiao Z; Gu WZ; Xue J; Bui MH; Merta P; Kovar P; Bouska JJ; Zhang H; Park C; Stewart KD; Sham HL; Sowin TJ; Rosenberg SH; Lin NH
    J Med Chem; 2007 Aug; 50(17):4162-76. PubMed ID: 17658776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyanopyrazin-2-yl)ureas [correction of cyanopyrazi] as potent and selective inhibitors of Chk1 kinase: synthesis, preliminary SAR, and biological activities.
    Wang GT; Li G; Mantei RA; Chen Z; Kovar P; Gu W; Xiao Z; Zhang H; Sham HL; Sowin T; Rosenberg SH; Lin NH
    J Med Chem; 2005 May; 48(9):3118-21. PubMed ID: 15857116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of 4'-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors.
    Tao ZF; Li G; Tong Y; Chen Z; Merta P; Kovar P; Zhang H; Rosenberg SH; Sham HL; Sowin TJ; Lin NH
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4308-15. PubMed ID: 17544271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of potential Rho-kinase inhibitors based on the chemistry of an original heterocycle: 4,4-dimethyl-3,4-dihydro-1H-quinolin-2-one.
    Letellier MA; Guillard J; Caignard DH; Ferry G; Boutin JA; Viaud-Massuard MC
    Eur J Med Chem; 2008 Aug; 43(8):1730-6. PubMed ID: 18164518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitigation of Acetylcholine Esterase Activity in the 1,7-Diazacarbazole Series of Inhibitors of Checkpoint Kinase 1.
    Gazzard L; Williams K; Chen H; Axford L; Blackwood E; Burton B; Chapman K; Crackett P; Drobnick J; Ellwood C; Epler J; Flagella M; Gancia E; Gill M; Goodacre S; Halladay J; Hewitt J; Hunt H; Kintz S; Lyssikatos J; Macleod C; Major S; Médard G; Narukulla R; Ramiscal J; Schmidt S; Seward E; Wiesmann C; Wu P; Yee S; Yen I; Malek S
    J Med Chem; 2015 Jun; 58(12):5053-74. PubMed ID: 25988399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of substituted 3-anilino-quinolin-2(1H)-ones as PDK1 inhibitors.
    O'Brien NJ; Brzozowski M; Wilson DJ; Deady LW; Abbott BM
    Bioorg Med Chem; 2014 Jul; 22(14):3781-90. PubMed ID: 24856302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening.
    Foloppe N; Fisher LM; Howes R; Potter A; Robertson AG; Surgenor AE
    Bioorg Med Chem; 2006 Jul; 14(14):4792-802. PubMed ID: 16574416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors.
    Han SY; Choi JW; Yang J; Chae CH; Lee J; Jung H; Lee K; Ha JD; Kim HR; Cho SY
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2837-42. PubMed ID: 22450128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of 6-substituted indolylquinolinones as potent Chek1 kinase inhibitors.
    Huang S; Garbaccio RM; Fraley ME; Steen J; Kreatsoulas C; Hartman G; Stirdivant S; Drakas B; Rickert K; Walsh E; Hamilton K; Buser CA; Hardwick J; Mao X; Abrams M; Beck S; Tao W; Lobell R; Sepp-Lorenzino L; Yan Y; Ikuta M; Murphy JZ; Sardana V; Munshi S; Kuo L; Reilly M; Mahan E
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5907-12. PubMed ID: 16990002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity.
    Foloppe N; Fisher LM; Howes R; Kierstan P; Potter A; Robertson AG; Surgenor AE
    J Med Chem; 2005 Jun; 48(13):4332-45. PubMed ID: 15974586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological activities of new checkpoint kinase 1 inhibitors structurally related to granulatimide.
    Conchon E; Anizon F; Aboab B; Prudhomme M
    J Med Chem; 2007 Sep; 50(19):4669-80. PubMed ID: 17722905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of granulatimide and isogranulatimide analogues as potential Chk1 inhibitors: Study of amino-platforms for their synthesis.
    Lavrard H; Rodriguez F; Delfourne E
    Bioorg Med Chem; 2014 Sep; 22(17):4961-7. PubMed ID: 25047935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel checkpoint kinase 1 inhibitors by virtual screening based on multiple crystal structures.
    Li Y; Kim DJ; Ma W; Lubet RA; Bode AM; Dong Z
    J Chem Inf Model; 2011 Nov; 51(11):2904-14. PubMed ID: 21955044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases.
    Nishiguchi GA; Atallah G; Bellamacina C; Burger MT; Ding Y; Feucht PH; Garcia PD; Han W; Klivansky L; Lindvall M
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6366-9. PubMed ID: 21945284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors.
    Oza V; Ashwell S; Brassil P; Breed J; Ezhuthachan J; Deng C; Grondine M; Horn C; Liu D; Lyne P; Newcombe N; Pass M; Read J; Su M; Toader D; Yu D; Yu Y; Zabludoff S
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2330-7. PubMed ID: 22342147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationships of soluble 8-substituted 4-(2-chlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of the Wee1 and Chk1 checkpoint kinases.
    Smaill JB; Lee HH; Palmer BD; Thompson AM; Squire CJ; Baker EN; Booth RJ; Kraker A; Hook K; Denny WA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):929-33. PubMed ID: 18191399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and in vitro evaluation of potent kinase inhibitors: Pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines.
    Alberti MJ; Auten EP; Lackey KE; McDonald OB; Wood ER; Preugschat F; Cutler GJ; Kane-Carson L; Liu W; Jung DK
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3778-81. PubMed ID: 15993060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates.
    Dudkin VY; Rickert K; Kreatsoulas C; Wang C; Arrington KL; Fraley ME; Hartman GD; Yan Y; Ikuta M; Stirdivant SM; Drakas RA; Walsh ES; Hamilton K; Buser CA; Lobell RB; Sepp-Lorenzino L
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2609-12. PubMed ID: 22374217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications for selectivity of 3,4-diarylquinolinones as p38alphaMAP kinase inhibitors.
    Peifer C; Urich R; Schattel V; Abadleh M; Röttig M; Kohlbacher O; Laufer S
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1431-5. PubMed ID: 18207396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors.
    Das J; Moquin RV; Pitt S; Zhang R; Shen DR; McIntyre KW; Gillooly K; Doweyko AM; Sack JS; Zhang H; Kiefer SE; Kish K; McKinnon M; Barrish JC; Dodd JH; Schieven GL; Leftheris K
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2652-7. PubMed ID: 18359226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.